Breast Cancer Foundation NZ
PAM trial
The PAM study is designed to explore the effects of combining a talk therapy called meaning-centred psychotherapy with repeated microdoses (very small doses) of LSD on psychological well-being and cancer-related distress.
This study is designed to explore the effects of combining a talk therapy called meaning-centred psychotherapy with repeated microdoses (very small doses) of LSD on psychological well-being and cancer-related distress.
What's involved?
- One screening visit to the University of Auckland
- Receiving either a low dose [microdose] of a psychedelic (LSD) or a placebo totake over six weeks (13 doses in total)
- Receiving seven sessions of psychotherapy over the six weeks
Eligibility criteria
- Diagnosis with a incurable Stage IV solid organ malignancy
- At least 6-month prognosis at screening
- Moderate to severe distress
- At least 25 years old
- No cerebral metastases
New Zealand
Australia
If you think you might be a candidate for this trial, use the contact details supplied, or talk to your doctor.
Want to access a trial that's not in your area? It's not always possible, but if you're interested, email us at intouch@bcf.org.nz
Similar clinical trials
For Advanced Breast Cancer , Supportive Care
Are we out of date? If you have updated or new information about a trial, we’d be grateful if you’d share it with us – email your update to intouch@bcf.org.nz
Interested in a clinical trial?
Subscribe for updates & stay in the loop with new studies.